1. Home
  2. BCAB vs FAT Comparison

BCAB vs FAT Comparison

Compare BCAB & FAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCAB
  • FAT
  • Stock Information
  • Founded
  • BCAB 2007
  • FAT 2017
  • Country
  • BCAB United States
  • FAT United States
  • Employees
  • BCAB N/A
  • FAT 8845
  • Industry
  • BCAB Medicinal Chemicals and Botanical Products
  • FAT Restaurants
  • Sector
  • BCAB Health Care
  • FAT Consumer Discretionary
  • Exchange
  • BCAB Nasdaq
  • FAT Nasdaq
  • Market Cap
  • BCAB 40.5M
  • FAT 33.6M
  • IPO Year
  • BCAB 2020
  • FAT 2017
  • Fundamental
  • Price
  • BCAB $0.76
  • FAT $1.90
  • Analyst Decision
  • BCAB Hold
  • FAT Strong Buy
  • Analyst Count
  • BCAB 3
  • FAT 1
  • Target Price
  • BCAB $1.00
  • FAT $10.00
  • AVG Volume (30 Days)
  • BCAB 1.4M
  • FAT 59.5K
  • Earning Date
  • BCAB 11-05-2025
  • FAT 10-30-2025
  • Dividend Yield
  • BCAB N/A
  • FAT 7.37%
  • EPS Growth
  • BCAB N/A
  • FAT N/A
  • EPS
  • BCAB N/A
  • FAT N/A
  • Revenue
  • BCAB $11,000,000.00
  • FAT $577,500,000.00
  • Revenue This Year
  • BCAB N/A
  • FAT N/A
  • Revenue Next Year
  • BCAB N/A
  • FAT $7.74
  • P/E Ratio
  • BCAB N/A
  • FAT N/A
  • Revenue Growth
  • BCAB N/A
  • FAT 0.96
  • 52 Week Low
  • BCAB $0.24
  • FAT $1.65
  • 52 Week High
  • BCAB $2.53
  • FAT $4.10
  • Technical
  • Relative Strength Index (RSI)
  • BCAB 52.28
  • FAT 43.80
  • Support Level
  • BCAB $0.61
  • FAT $1.65
  • Resistance Level
  • BCAB $1.06
  • FAT $2.00
  • Average True Range (ATR)
  • BCAB 0.13
  • FAT 0.10
  • MACD
  • BCAB -0.02
  • FAT -0.01
  • Stochastic Oscillator
  • BCAB 32.78
  • FAT 55.56

About BCAB BioAtla Inc.

BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.

About FAT FAT Brands Inc.

FAT Brands Inc is a multi-brand restaurant franchising company. It develops, markets, acquires, and manages quick service, fast casual, casual dining, and polished casual dining restaurant concepts around the world. The company operates as a franchisor of restaurants, where the company generally does not own or operate the restaurant locations but rather generates revenue by charging franchisees an initial franchise fee as well as ongoing royalties. For some of the company's brands, it also directly owns and operates restaurant locations. Its brands include Round Table Pizza, Fatburger, Johnny Rockets, Twin Peaks, and Elevation Burger among others. Geographically, the majority of the revenue for the company is generated from the United States.

Share on Social Networks: